Zhiwei, C., Yang, F., Luo, Y., Sun, L., Wu, L., Han, Z., Fan, Y., Zhao, Y., Li, X., Xu, H., Meng, X., Liu, Y., Zhang, Z., Luo, H., Shi, Q., Ma, X., Ma, X., Zhang, Z., Xia, M. Y., Lu, S. (2026). Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in previously untreated advanced squamous non–small cell lung cancer: Overall survival results of the phase 3 HARMONi-6 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba4